
Biosimilars have become increasingly popular in the last few years.
Recently, there's been an uptick in studies and articles about functional dyspepsia (FD). The reason is probably that FD is quite common (10% to 15% of the US population has it), and many clinicians fail to differentiate FD from other gastrointestinal disturbances.
Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), describes how pharmacy school curriculums have changed.
No. 1 Print and Online Source for Pharmacists Takes to Social Media to #ThankAPharmacist
Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), discusses collaborations with the AACP.
Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), explains how pharmacies can become sites for student rotations.
Teva has just launched daptomycin for injection, a generic version of Cubicin, in the US market.
Nearly 300 Attendees Received Flu Shots and Health Screenings
Medicines for Europe and GPhA are committed to supporting positive developments of the negotiations for a TTIP and in particular the regulatory cooperation of pharmaceuticals therein.
In case you missed it...
The American Academy of Pediatrics (AAP) is now advising against giving codeine to children.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), explains how practicing pharmacists can become preceptors.
Virtus Pharmaceuticals Opco II is recalling 7 batches of hyoscyamine sulfate 0.125 mg, which include tablet, sublingual, and orally disintegrating tablet forms, due to superpotent and subpotent test results.
Lynette Bradley-Baker, PhD, RPh, vice president of public affairs and engagement of the American Association of Colleges of Pharmacy (AACP), discusses how students can engage with the AACP.
ASCP Looks to Fast-Paced October and November
Flu vaccines are already available at many retail pharmacy locations, though the flu season typically starts on October 1.
About 1 in 3 individuals in the United States will develop shingles in their lifetime.
The pharmacy profession seems to be decreasing in popularity among millennials.
A Dallas pharmacist has pleaded guilty to a conspiracy charge for his involvement in a pill mill" operation to distribute oxycodone illegally in Texas.
When that same ole, same ole" feeling starts to kick in, look for opportunities to expand what you know.
As medicines advance and ailments transform, our continuing education becomes even more important.
Facebook is a critical place for businesses to engage.
This new program will help with the shortage of Hispanic, Latino, and Spanish-speaking health care providers in the area.
Without an effective social media presence, you may never know how your brand's being represented online.
Allergan and Medicines360 have just launched a single-handed inserter for their Liletta levonorgestrel-releasing intrauterine device (IUD), which can prevent pregnancy up to 3 years.
The great debate of whether pharmacies should dispense clean needles and syringes to injectable drug users has resurfaced. Although some critics view it as pure evil, I find it purely necessary. When patients come in for the needles, I gladly sell them.
The FDA has just approved Janssen's Invokamet XR, a once-daily, fixed-dose combination of canagliflozin (Invokana) and extended-release metformin hydrochloride, for first-line treatment for type 2 diabetes in adults as an adjunct to diet and exercise.
The herbal supplement kratom will be banned from drugstore shelves effective October 1, 2016.
Just as medication errors can't be blamed on an individual pharmacist, the EpiPen pricing issue shouldn't be blamed on one stakeholder.